Trial Profile
Nexium Capsules Specific Clinical Experience Investigation for Long-term Use Concerning Prevention of Recurrence of Gastric Ulcer or Duodenal Ulcer With NSAIDs
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2017
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary)
- Indications NSAID-induced ulcer
- Focus Adverse reactions
- Sponsors AstraZeneca
- 17 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Aug 2015 Planned End Date changed from 1 Jun 2017 to 1 Aug 2015 as per ClinicalTrials.gov record.
- 05 Aug 2015 Planned primary completion date changed from 1 Dec 2016 to 1 Aug 2015 as per ClinicalTrials.gov record..